1. Introduction {#sec1}
===============

Head and neck squamous cell carcinoma (HNSCC) is the most frequent malignancy of the upper aerodigestive tract in humans \[[@B1]\].

Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) provide the mainstay of imaging for diagnosis, staging, and treatment response assessment in HNSCC \[[@B2]\]. Functional imaging such as positron emission tomography (PET), diffusion weighted imaging (DWI), and dynamic contrast-enhanced (DCE) MRI provide complementary information on the underlying biology such as metabolic activity, cellularity, vascularity, and oxygenation \[[@B2], [@B3]\].

It has been shown that HNSCC lesions had high standardized uptake values (SUV) and low apparent diffusion coefficient (ADC) values \[[@B4], [@B5]\]. Furthermore, malignant tumors showed also high perfusion parameters in comparison to benign lesions \[[@B6]\].

Some authors performed multiparametric investigation of HNSCC including ^18^F fluorodeoxyglucose PET (^18^F-FDG-PET), DWI, and DCE and attempted to characterize complexity of imaging findings reflecting tumor biology \[[@B3], [@B7], [@B8]\]. The reported data, however, were inconsistent. Some authors found significant correlations between analyzed parameters and, therefore, suggested complex interactions among tumor biologic characteristics \[[@B7]--[@B10]\]. Thereby, DWI, PET, and DCE parameters were reported to have similar potential to characterize HNSCC \[[@B10]\]. For example, Nakajo et al. showed that both SUV and ADC values correlated well together and could similarly predict disease-free survival or disease events in HNSCC \[[@B10]\].

However, in other studies, no significant correlations between these parameters were identified \[[@B11]--[@B13]\]. Therefore, it has been mentioned that parameters derived from PET, DWI, and DCE are independent biomarkers and complement one another \[[@B11]--[@B15]\].

This discrepancy of reported data questions the possibility of using multiparametric imaging findings as surrogate markers of tumor consistency in HNSCC.

The analysis of possible relationships between microcirculation, cellularity, and glucose metabolism has not only scientific importance but also clinical significance. As mentioned previously, an understanding of such complexities could expand the knowledge of tumor characteristics and have clinical implications such as in guidance for treatment planning, early prediction of treatment responses, and evaluation of treatment outcome \[[@B3]\].

The purpose of this study was to analyze possible associations between multiparametric imaging findings of simultaneous ^18^F-FDG-PET/MR including DWI and DCE in patients with HNSCC.

2. Materials and Methods {#sec2}
========================

This prospective study was approved by the institutional review board of the University of Leipzig and all patients gave their written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.

2.1. Patients {#sec2.1}
-------------

Overall, 34 patients with primary HNSCC of different localizations were involved in the study ([Table 1](#tab1){ref-type="table"}). There were 9 (26%) women and 25 (74%) men with a mean age of 56.7 ± 10.2 years, range 33--77 years. At initial presentation, the tumors were localized in the tonsil (23.6%), followed by oropharynx (20.6%) and tongue (20.6%), hypopharynx (17.6%), larynx (14.6%), and epipharynx (2.9%). In most cases, high grade lesions (51.8%) were diagnosed. Furthermore, most frequently, the identified lesions were staged as T3 (29.4%) or T4 tumors (47.1%) with additional nodal (91.2%) metastases ([Table 1](#tab1){ref-type="table"}).

2.2. Imaging {#sec2.2}
------------

### 2.2.1. Simultaneous PET/MR {#sec2.2.1}

In all patients a simultaneous ^18^F-FDG-PET/MR (Magnetom Biograph mMR-Biograph, Siemens Healthcare Sector, Erlangen, Germany) was performed from the upper thigh to the skull after a fasting period of at least 6 hours. Application of ^18^F-FDG was performed intravenously with a body weight-adapted dose (4 MBq/kg, range: 168--427 MBq, and mean ± SD: 279 ± 60 MBq). PET/MR image acquisition started on average 170 minutes (range 60--300 minutes) after ^18^F-FDG application. In 28/34 patients a PET/CT scan was performed prior to PET/MRI, which explains the later PET/MRI image acquisition time in these patients. For attenuation correction of the PET data a coronal 3D-encoded gradient-echo sequence (Dixon-VIBE) was used. For each tumor, maximum and mean SUV (SUV~max~; SUV~mean~) were determined.

PET images were analyzed by one nuclear medicine physician (S. P.) with 7 years of experience.

2.3. Image Interpretation {#sec2.3}
-------------------------

PET/MR datasets were evaluated by a board certified nuclear medicine and a board certified radiologist with substantial PET/MR experience in oncological image interpretation. PET/MR image analysis was performed on the dedicated workstation of Hermes Medical Solutions, Sweden.

Tumor margins of the HNSCC were identified on MR images (T1-sequence) and a polygonal volume of interest (VOI) was placed in the fused PET/MR dataset (SUV~max~ threshold 40%) ([Figure 1(a)](#fig1){ref-type="fig"}).

2.4. DWI {#sec2.4}
--------

DWI was obtained by using an axial EPI (echo planar imaging) sequence with *b*-values of 0 and 800 s/mm^2^ (TR/TE: 8620/73 ms, slice thickness 4 mm, and voxel size 3.2 × 2.6 × 4.0 mm). ADC maps were automatically generated by the implemented software. DWI images were analyzed by one radiologist (L. L., 2 years of general radiological experience). Polygonal regions of interest (ROI) were manually drawn on the ADC maps along the contours of the tumor on each slice ([Figure 1(b)](#fig1){ref-type="fig"}). In all lesions minimal ADC values (ADC~min~), mean ADC values (ADC~mean~), and maximal ADC values (ADC~max~) were estimated ([Figure 1(b)](#fig1){ref-type="fig"}).

2.5. DCE {#sec2.5}
--------

In 31 patients, DCE MRI was performed by using dynamic T1w DCE sequence (TR/TE 2.47/0.97 ms, slice thickness 5 mm, flip angle 8°, and voxel size 1.2 × 1.0 × 5.0 mm) after intravenous application of contrast medium (0.1 mmol Gadobutrol per kg of body weight) (Gadovist®, Bayer Healthcare, Leverkusen, Germany) as reported previously \[[@B8], [@B15]\]. The acquired images were transferred to a software module for tissue perfusion estimation (Tissue 4D, Siemens Medical Systems, Erlangen, Germany). The software offers a population based approach for the arterial input function (AIF) and the best of three available AIF-options was chosen according to the result of the chi2-parameter, which serves as an error measure for the model fit \[[@B7], [@B8]\]. The AIF was scaled in relation to the gadolinium dose and modelled according to the biexponential model of Tofts and Kermode \[[@B16]\]. The following pharmacokinetic parameters \[[@B7], [@B8], [@B15]\] were automatically calculated for whole lesion in every case (Figures [1(c)](#fig1){ref-type="fig"}--[1(e)](#fig1){ref-type="fig"}):*K*~trans~: volume transfer constant, which estimates the diffusion of contrast medium from the plasma through the vessel wall into the interstitial space, representing vessel permeability*V*~*e*~: volume of the extravascular extracellular leakage space (EES)*K*~ep~: parameter for diffusion of contrast medium from the EES back to the plasma. It is in close relation with *K*~trans~ and *V*~*e*~ and is calculated by the formula *k*~ep~ = *K*~trans~ × *V*~*e*~^−1^.DCE images were analyzed by one radiologist (L. L., 2 years of general radiological experience).

2.6. Statistical Analysis {#sec2.6}
-------------------------

Statistical analysis and graphics creation were performed using SPSS 20 (IBM SPSS Statistics, Armonk, New York, USA). Collected data were evaluated by means of descriptive statistics (absolute and relative frequencies). Spearman\'s correlation coefficient (*p*) was used to analyze associations between investigated parameters. *P* values \< 0.05 were taken to indicate statistical significance.

3. Results {#sec3}
==========

A complete overview of the results including mean values, standard deviation, and ranges is shown in [Table 2](#tab2){ref-type="table"}.

Сorrelation analysis identified the following: in overall sample, ADC~mean~ correlated significantly well with *V*~*e*~ (*P* = 0.0002) and slightly with *K*~trans~ (0.04), ADC~min~ correlated with *V*~*e*~ (*P* = 0.0007), and ADC~max~ correlated with *K*~trans~ (0.0032) and *V*~*e*~ (0.045) ([Table 3](#tab3){ref-type="table"}). *K*~trans~ correlated well with *K*~ep~ (*P* = 0.0017) and *V*~*e*~ (*P* = 0.0002).

In addition, SUV~max~ tended to correlate slightly inversely with ADC~min~ (*P* = 0.08) and SUV~mean~ had a tendency to correlate with *K*~trans~ (*P* = 0.08).

On the next step, the estimated parameters were correlated in different tumor subgroups. In G1/2 tumors, *K*~trans~ correlated well with ADC~max~ and SUV~mean~ ([Table 4](#tab4){ref-type="table"}). No other significant correlations were identified. SUV~max~ tended to correlate inversely with ADC~min~ (*P* = 0.09). *V*~*e*~ had a tendency to correlate with ADC~mean~ and ADC~min~ (in both cases, *P* = 0.08). In addition, DCE parameters did not correlate together.

However, in G3 tumors, *K*~trans~ correlated well with *K*~ep~ (*P* = 0.015) and *V*~*e*~ (*P* = 0.003) ([Table 5](#tab5){ref-type="table"}). *V*~*e*~ showed significant strong correlations with ADC~mean~ (*P* = 0.0014) and ADC~min~ (*P* = 0.01). *K*~trans~ correlated moderately with ADC~max~ (*P* = 0.04). Finally, SUV values did not correlate with ADC and perfusion parameters.

No significant differences were identified in the analyzed parameters between poorly and moderately/well differentiated tumors ([Table 6](#tab6){ref-type="table"}).

There were no significant differences of the analyzed parameters between several tumor stages (Tables [7](#tab7){ref-type="table"}(a)--[7](#tab7){ref-type="table"}(c)). Only *K*~ep~ was higher in cancers with N2/3 stages versus N0/1 stages ([Table 7(b)](#tab7){ref-type="table"}).

4. Discussion {#sec4}
=============

Our study identified several significant associations between PET, DWI, and DCE parameters in primary HNSCC in a complex investigation.

The analysis of previous studies regarding multiparametric imaging findings in HNSCC shows that the reported results are controversial. This applies both comparisons of the investigated parameters in different tumor stages and correlation between the variables. For example, Fruehwald-Pallamar et al. analyzed sequentially acquired ^18^F-FDG-PET and MR images of 31 HNSCC patients and did not observe significant differences in ADC values and SUV~max~ between various T stages of the investigated tumors \[[@B11]\]. However, Kim et al. found that T3/4 tumors had higher SUV~max~ values than T1/2 lesions \[[@B17]\]. In addition, N positive tumors showed also higher SUV~max~ values \[[@B17]\]. According to Zhang et al., T3/4 tumors showed statistically significant higher ADC values in comparison to T1/2 lesions \[[@B18]\]. It has also been reported that DCE parameters correlated well with tumor stage in nasopharyngeal carcinoma \[[@B19]\].

In the present study, we also identified significant differences in analyzed parameters between several tumor stages. Firstly, advanced carcinomas had higher SUV~max~ values. However, there were no significant differences in other investigated parameters between T1/2 and T3/4 tumors. This finding suggests that advanced tumors have higher metabolic activity but not higher cell density or perfusion. Secondly, *K*~ep~ was higher in N2 tumors. Previously, strong correlations between *K*~ep~ and microvessel density in HNSCC were reported \[[@B15]\]. Therefore, our findings may indicate that tumor microvessel density might influence lymphatic metastatic spread in HNSCC.

To the best of our knowledge, previously, only two studies investigated associations between imaging findings and tumor grading in HNSCC \[[@B11], [@B12]\]. So, Choi et al. mentioned that poorly differentiated tumors had statistically significant lower ADC values and higher SUV values than G1/G2 tumors \[[@B12]\]. Other authors, however, reported that SUV and ADC values could not distinguish tumor stages \[[@B11]\]. Also in the present study no significant differences were identified between well/moderately and poorly differentiated carcinomas. Grading system of HNSCC includes the following parameters: degree of keratinization, nuclear pleomorphism, number of mitoses, pattern of invasion, and presence or absence of inflammatory infiltrates \[[@B20], [@B21]\]. However, this system does not include parameters, such as cell count, cell size, extracellular space, and microvessel density, which are known to influence water diffusion, glucose metabolism, and perfusion. This may explain our negative results regarding associations between tumor grading and multiparametric imaging findings.

According to previous reports, several parameters of tumor perfusion, diffusion, and glucose metabolism were associated together \[[@B7]--[@B10]\]. So Bisdas et al. identified significant correlations between SUV values and *V*~*e*~ (*p* = 0.42, *P* = 0.03) \[[@B7]\]. Furthermore, analyzed perfusions parameter (*K*~trans~, *V*~*e*~, and *K*~ep~) also correlated well together \[[@B7]\]. In the study of Nakajo et al., a statistically significant inverse correlation between SUV~max~ and ADC~mean~ (*p* = −0.566, *P* = 0.005) was found \[[@B10]\]. Additionally, according to Covello et al., ADC~mean~ correlated inversely with K~trans~ (*p* = −0.42, *P* = 0.04) \[[@B9]\].

However, other authors did not identify significant correlations between analyzed parameters \[[@B11]--[@B13]\]. For instance, Rasmussen et al. could not find significant associations between SUV and ADC values \[[@B13]\]. Similar results were also reported in other researches \[[@B11], [@B12], [@B14]\]. Furthermore, Han et al. detected no significant associations between DCE and glucose metabolism parameters in HNSCC \[[@B3]\].

It is still unclear why some authors found significant correlations between water diffusion, glucose metabolism, and perfusion parameters in HNSCC while others did not. Presumably, tumor heterogeneity may play a role here. For example, well, moderately, and poorly differentiated tumors might show also different associations of imaging parameters. In fact, our results confirmed this hypothesis.

In the present study, no significant correlations between different ADC parameters and SUV values were identified in overall sample. Furthermore, SUV~max~ tended to correlate slightly with *K*~trans~ and ADC~min~. All ADC parameters showed significant associations with *V*~*e*~. In addition, *K*~trans~ correlated slightly with ADC~mean~ and moderately with ADC~max~ and *K*~ep~ and well with *V*~*e*~.

Separate correlation analyses in the G1/2 and G3 tumors showed, however, other associations between the investigated parameters. As seen, perfusion parameters *K*~trans~, *V*~*e*~, and *K*~ep~ did not significantly correlate together in well and moderately differentiated tumors. However, they correlated well in high grade carcinomas. Additionally, *K*~trans~ correlated well with SUV~mean~ in G1/2 lesions but not in G3 tumors. Finally, *V*~*e*~ correlated well with ADC~mean~ and ADC~min~ in G3 tumors, but not in G1/2 lesions.

Our data suggest that tumor metabolism, cellularity, and perfusion show complex relationships in HNSCC. Furthermore, these associations depend on tumor grading. Previously, it has been shown that SUV and ADC values as well as perfusion parameters correlated with different histopathological features in HNSCC \[[@B14], [@B15]\]. We hypothesize on the basis of our findings that tumors with different grading may have also different relationships between cell count, stroma, and microvessel density, that is, different tumor architecture. Furthermore, our data suggest that tissue architecture plays a great role in tumor characteristic. Our findings may also explain controversial data of previous reports. Presumably, previous studies might contain well, moderately, and poorly differentiated lesions in several proportions that may result in different associations between the analyzed parameters.

In conclusion, multiparameter imaging provides information regarding tumor composition. Our study shows that tumor metabolism, water diffusion, and tumor perfusion have complex relationships in HNSCC. Furthermore, these associations depend on tumor grading. Perfusion parameter *K*~ep~ may predict lymphonodal metastasizing.
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###### 

Localization and stage of the identified tumors.

                             *n* (%)
  -------------------------- -----------
  *Diagnosis*                 
  Carcinoma of epipharynx    1 (2.9)
  Carcinoma of oropharynx    7 (20.6)
  Carcinoma of hypopharynx   6 (17.6)
  Carcinoma of larynx        5 (14.7)
  Carcinoma of tongue        7 (20.6)
  Tonsillar carcinoma        8 (23.6)
  *Tumor stage*               
  T stage                     
  T1                         1 (2.9)
  T2                         7 (20.6)
  T3                         10 (29.4)
  T4                         16 (47.1)
  *N stage*                   
  N0                         3 (8.8)
  N1                         6 (17.7)
  N2                         22 (64.7)
  N3                         3 (8.8)
  *M stage*                   
  M0                         30 (88.2)
  M1                         4 (11.8)
  *Tumor grading*             
  G1                         1 (2.9)
  G2                         12 (35.3)
  G3                         21 (51.8)

###### 

DWI, PET, and DCE parameters of HNSCC.

  Parameters                       M ± SD         Range
  -------------------------------- -------------- -------------
  SUV~max~                         19.01 ± 9.81   5.81--48.00
  SUV~mean~                        8.19 ± 3.55    3.76--17.70
  ADC~mean~  × 10^−3^ mm^2^s^−1^   1.14 ± 0.21    0.78--1.68
  ADC~min~  × 10^−3^ mm^2^s^−1^    0.71 ± 0.23    0.17--1.24
  ADC~max~  × 10^−3^ mm^2^s^−1^    1.77 ± 0.30    1.35--2.39
  *K* ~trans~                      0.20 ± 0.12    0.01--0.53
  *K* ~ep~                         0.58 ± 0.69    0.16--3.37
  *V* ~*e*~                        0.51 ± 0.18    0.05--0.79

###### 

Correlations between DCE, DWI, and PET parameters in all tumors.

  Parameters        SUV~max~         SUV~mean~        ADC~mean~        ADC~min~         ADC~max~       *K* ~trans~    *K* ~ep~       *V* ~*e*~
  ----------------- ---------------- ---------------- ---------------- ---------------- -------------- -------------- -------------- --------------
  SUV~max~          ---              **p** = 0.86     *p* = −0.25      *p* = −0.30      *p* = 0.18     *p* = 0.09     *p* = 0.10     *p* = −0.07
  **P** \< 0.0001   *P* = 0.15       *P* = 0.08       *P* = 0.32       *P* = 0.63       *P* = 0.59     *P* = 0.70                    
  SUV~mean~                          ---              *p* = −0.08      *p* = −0.15      *p* = 0.22     *p* = 0.32     *p* = 0.26     *p* = 0.13
  *P* = 0.67        *P* = 0.39       *P* = 0.22       *P* = 0.08       *P* = 0.16       *P* = 0.49                                   
  ADC~mean~                                           ---              **p** = 0.88     **p** = 0.54   **p** = 0.37   *p* = −0.10    **p** = 0.62
  **P** \< 0.0001   **P** = 0.0009   **P** = 0.04     *P* = 0.847      **P** = 0.0002                                                
  ADC~min~                                                             ---              *p* = 0.27     *p* = 0.26     *p* = −0.08    **p** = 0.58
  *P* = 0.12        *P* = 0.16       *P* = 0.65       **P** = 0.0007                                                                 
  ADC~max~                                                                                             **p** = 0.51   *p* = 0.12     **p** = 0.36
  **P** = 0.003     *P* = 0.52       **P** = 0.0445                                                                                  
  *K* ~trans~                                                                                                         **p** = 0.54   **p** = 0.62
  **P** = 0.0017    **P** = 0.0002                                                                                                   
  *K* ~ep~                                                                                             ---            ---            *p* = −0.12
  *P* = 0.51                                                                                                                         
  *V* ~*e*~                                                                                                                          ---

Significant correlations are highlighted in bold.

###### 

Correlations between DCE, DWI, and PET parameters in G1 and 2 tumors.

  Parameters       SUV~max~        SUV~mean~      ADC~mean~      ADC~min~       ADC~max~       *K* ~trans~    *K* ~ep~      *V* ~*e*~
  ---------------- --------------- -------------- -------------- -------------- -------------- -------------- ------------- -------------
  SUV~max~         ---             **p** = 0.74   *p* = −0.47    *p* = −0.49    *p* = 0.10     *p* = 0.27     *p* = 0.16    *p* = 0.14
  **P** = 0.0041   *P* = 0.10      *P* = 0.09     *P* = 0.75     *P* = 0.42     *P* = 0.63     *P* = 0.69                   
  SUV~mean~                        ---            *p* = −0.23    *p* = −0.29    *p* = 0.31     **p** = 0.65   *p* = 0.24    *p* = 0.34
  *P* = 0.45       *P* = 0.34      *P* = 0.30     **P** = 0.03   *P* = 0.48     *P* = 0.31                                  
  ADC~mean~                                       ---            **p** = 0.68   **p** = 0.56   *p* = 0.44     *p* = −0.10   *p* = 0.55
  **P** = 0.01     **P** = 0.046   *P* = 0.18     *P* = 0.77     *P* = 0.08                                                 
  ADC~min~                                                       ---            *p* = −0.08    *p* = 0.22     *p* = 0.11    *p* = 0.55
  *P* = 0.79       *P* = 0.52      *P* = 0.75     *P* = 0.08                                                                
  ADC~max~                                                                                     **p** = 0.65   *p* = 0.09    *p* = 0.25
  **P** = 0.03     *P* = 0.79      *P* = 0.45                                                                               
  *K* ~trans~                                                                                                 *p* = 0.36    *p* = 0.500
  *P* = 0.27       *P* = 0.12                                                                                               
  *K* ~ep~                                                                                                                  *p* = −0.37
  *P* = 0.26                                                                                                                
  *V* ~*e*~                                                                                                                  

Significant correlations are highlighted in bold.

###### 

Correlations between DCE, DWI, and PET parameters in G3 tumors.

  Parameters        SUV~max~        SUV~mean~      ADC~mean~      ADC~min~         ADC~max~       *K* ~trans~    *K* ~ep~       *V* ~*e*~
  ----------------- --------------- -------------- -------------- ---------------- -------------- -------------- -------------- --------------
  SUV~max~          ---             **p** = 0.85   *p* = −0.25    *p* = −0.26      *p* = 0.11     *p* = 0.02     *p* = 0.15     *p* = −0.24
  **P** \< 0.0001   *P* = 0.28      *P* = 0.27     *P* = 0.65     *P* = 0.95       *P* = 0.54     *P* = 0.33                    
  SUV~mean~                         ---            *p* = −0.11    *p* = −0.09      *p* = 0.05     *p* = 0.10     *p* = 0.34     *p* = −0.12
  *P* = 0.63        *P* = 0.71      *P* = 0.82     *P* = 0.69     *P* = 0.16       *P* = 0.63                                   
  ADC~mean~                                        ---            **p** = 0.94     **p** = 0.60   *p* = 0.33     *p* = −0.15    **p** = 0.68
  **P** \< 0.0001   **P** = 0.005   *P* = 0.17     *P* = 0.55     **P** = 0.0014                                                
  ADC~min~                                                        ---              **p** = 0.47   *p* = 0.18     *p* = −0.16    **p** = 0.57
  **P** = 0.04      *P* = 0.45      *P* = 0.52     **P** = 0.01                                                                 
  ADC~max~                                                                         ---            **p** = 0.48   *p* = 0.16     *p* = 0.37
  **P** = 0.04      *P* = 0.51      *P* = 0.12                                                                                  
  *K* ~trans~                                                                                     ---            **p** = 0.55   **p** = 0.65
  **P** = 0.015     **P** = 0.003                                                                                               
  *K* ~ep~                                                                                                       ---            *p* = −0.06
  *P* = 0.79                                                                                                                    
  *V* ~*e*~                                                                                                                     ---

Significant correlations are highlighted in bold.

###### 

Comparison of PET and DWI values between different tumor grades.

  Parameters                       G1 + 2         G3 + 4         Mann--Whitney *U*
  -------------------------------- -------------- -------------- -------------------
  SUV~max~                         21.11 ± 8.37   17.79 ± 9.86   0.20
  SUV~mean~                        8.92 ± 3.92    7.75 ± 3.40    0.28
  ADC~min~  × 10^−3^ mm^2^s^−1^    0.74 ± 0.15    0.69 ± 0.28    0.65
  ADC~mean~  × 10^−3^ mm^2^s^−1^   1.16 ± 0.14    1.13 ± 0.25    0.47
  ADC~max~  × 10^−3^ mm^2^s^−1^    1.75 ± 0.25    1.79 ± 0.34    0.96
  *K* ~trans~                      0.20 ± 0.13    0.20± 0.12     0.93
  *K* ~ep~                         0.39 ± 0.16    0.70 ± 0.85    0.22
  *V* ~*e*~                        0.55 ± 0.19    0.49 ± 0.17    0.37

###### 

\(a\) Comparison of PET and DWI values between different tumor T stages

  Parameters                       T1/2 (mean ± SD)   T3/4 (mean ± SD)   Mann--Whitney *U*
  -------------------------------- ------------------ ------------------ -------------------
  SUV~max~                         14.98 ± 7.88       20.25 ± 9.34       0.19
  SUV~mean~                        6.46 ± 1.60        8.73 ± 3.83        0.17
  ADC~min~  × 10^−3^ mm^2^s^−1^    0.64 ± 0.23        0.73 ± 0.23        0.41
  ADC~mean~  × 10^−3^ mm^2^s^−1^   1.09 ± 0.17        1.16 ± 0.21        0.56
  ADC~max~  × 10^−3^ mm^2^s^−1^    1.73 ± 0.33        1.78 ± 0.30        0.58
  *K* ~trans~                      0.17 ± 0.13        0.21 ± 0.11        0.27
  *K* ~ep~                         1.05 ± 1.25        0.42 ± 0.17        0.37
  *V* ~*e*~                        0.41 ± 0.22        0.55 ± 0.15        0.25

###### 

\(b\) Comparison of PET and DWI values between different tumor N stages

  Parameters                       N 0/1 (mean ± SD)   N 2 (mean ± SD)   Mann--Whitney *U*
  -------------------------------- ------------------- ----------------- -------------------
  SUV~max~                         19.72 ± 7.99        18.75 ± 9.72      0.78
  SUV~mean~                        8.50 ± 3.88         8.08 ± 3.50       0.97
  ADC~min~  × 10^−3^ mm^2^s^−1^    0.78 ± 0.24         0.69 ± 023        0.75
  ADC~mean~  × 10^−3^ mm^2^s^−1^   1.18 ± 0.24         1.13 ± 0.20       0.64
  ADC~max~  × 10^−3^ mm^2^s^−1^    1.78 ± 0.29         1.77 ± 0.31       0.88
  *K* ~trans~                      0.16 ± 0.08         0.22 ± 0.13       0.25
  *K* ~ep~                         0.32 ± 0.11         0.68 ± 0.79       **0.0477**
  *V* ~*e*~                        0.52 ± 0.18         0.50 ± 0.18       0.88

###### 

\(c\) Comparison of PET and DWI values between different tumor M stages

  Parameters    M0 (mean ± SD)   M1 (mean ± SD)   Mann--Whitney *U*
  ------------- ---------------- ---------------- -------------------
  SUV~max~      18.98 ± 9.14     16.49 ± 10.06    0.56
  SUV~mean~     8.01 ± 3.40      6.87 ± 1.50      0.60
  ADC~min~      0.68 ± 0.22      0.89 ± 0.28      0.21
  ADC~mean~     1.12 ± 0.19      1.28 ± 0.30      0.33
  ADC~max~      1.76 ± 0.30      1.89 ± 0.37      0.46
  *K* ~trans~   0.21 ± 0.12      0.14 ± 0.08      0.47
  *K* ~ep~      0.62 ± 0.72      0.28 ± 0.17      0.16
  *V* ~*e*~     0.50 ± 0.19      0.55 ± 0.10      0.78

[^1]: Academic Editor: Jie Lu
